[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619378":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":34,"responsibleParty":57,"collaborators":24,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":24,"eligibilityCriteria":67,"healthyVolunteers":63,"sex":68,"minAge":69,"maxAge":24,"enrollmentInfo":70,"targetDuration":24,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":24,"overallStatus":36,"whyStopped":24,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Benha University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Dexmedetomidine group","EXPERIMENTAL","Following confirmation of adequate spinal anesthesia, dexmedetomidine will be administered as an intravenous infusion of 0.2-0.4µg\u002Fkg\u002Fhr until abdominal closure.",[13],"Drug: Dexmedetomidine",{"label":15,"type":10,"description":16,"interventionNames":17},"Virtual reality group","Participants will be fitted with virtual reality headsets immediately after the establishment of spinal anesthesia. The headsets will display calming immersive audiovisual content, and participants will continue wearing them throughout the entire procedure until skin closure.",[18],"Other: Virtual reality",[20,25],{"type":21,"name":22,"description":11,"armGroupLabels":23,"otherNames":24},"DRUG","Dexmedetomidine",[9],null,{"type":6,"name":26,"description":16,"armGroupLabels":27,"otherNames":24},"Virtual reality",[15],[29],{"name":30,"role":31,"phone":32,"phoneExt":24,"email":33},"Emad M Sayed, MBBCH","CONTACT","00201111710428","dr.emad.mohamedsayed@gmail.com",[35],{"facility":5,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Banhā","Benha","13518","Egypt","EG",{"type":43,"coordinates":44},"Point",[45,46],31.1842,30.45977,{"lat":46,"lon":45},[49,50,53,55],{"name":30,"role":31,"phone":32,"phoneExt":24,"email":33},{"name":51,"role":52,"phone":24,"phoneExt":24,"email":24},"Saad I Saad, MD","SUB_INVESTIGATOR",{"name":54,"role":52,"phone":24,"phoneExt":24,"email":24},"Mohamed H Abdelrahman, MD",{"name":56,"role":52,"phone":24,"phoneExt":24,"email":24},"Mona S Emara, MD",{"type":58,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Emad Mohamed Sayed","Resident of Anesthesia and Intensive Care, Benha University, Benha, Egypt.","100619378","virtual-reality-versus-intravenous-dexmedetomidine-on-maternal-anxiety-stress-hemodynamics-and-neonatal-outcomes-during-cesarean-section-100619378",false,"NCT07343843","Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section","Effect of Virtual Reality Versus Intravenous Dexmedetomidine on Maternal Anxiety, Stress, Hemodynamics, and Neonatal Outcomes During Cesarean Section","Inclusion Criteria:\n\n* Age over 18 years old.\n* American Society of Anesthesiologists (ASA) physical status II.\n* Scheduled for elective cesarean section (CS) delivery under Central Neuraxial Blockade.\n* Provide informed consent and agree to participate in the study.\n\nExclusion Criteria:\n\n* Patient's refusal\n* Patient known have contraindications for Regional Anesthesia as infection at the site of injection, severe coagulopathy or allergy to local anesthetics.\n* Patient with psychiatric disorders.\n* Sensory impairment (blindness, deafness).\n* Any technical problem preventing proper fitting of the glasses to the patient face.\n* Patients with cognitive impairment, epilepsy or with claustrophobia\n* Patients with suspected eye infection\n* Signs of active labor.\n* Pregnancy related-diseases or antepartum hemorrhage.\n* Presence of Fetal distress.","FEMALE","18 Years",{"count":71,"type":72},52,"ESTIMATED","INTERVENTIONAL",[75],"NA","This study aims to compare the efficacy of intravenous dexmedetomidine infusion versus virtual reality (VR) in reducing maternal anxiety, stress, and hemodynamic instability during cesarean section and their effects on neonatal outcome as respiration and heart rate.",[78,22,79,80,81,82,83],"Virtual Reality","Maternal Anxiety","Stress","Hemodynamics","Neonatal Outcomes","Cesarean Section","2026-01-17",{"date":86,"type":87},"2026-01-21","ACTUAL",{"date":84,"type":87},{"date":90,"type":72},"2026-07-01",{"name":5,"class":6},1]